US Markets Overnight provide some relief for the high Beta crowd
Here is the thing about being the most important company on the planet: you can post numbers that would make any other CEO weep with joy and still get nothing but a red tick in afterhours for your trouble. That was Nvidia's lot on…
Tech Stocks
Test text
Hydrix (ASX:HYD) raised A$3.89m in the institutional leg of a 6-for-1 entitlement offer at A$0.005 to fund a defence technology pivot.
Catapult Sports (ASX:CAT) hits Rule of 40 in FY26 with ACV up 28% to US$133.8m and Management EBITDA jumping 67% to US$24.7m.
DorsaVi (ASX:DVL) has cleared one of the biggest technical hurdles facing its 22nm ReRAM program to date.
The company has developed three different recipes for its ReRAM memory cells, known in the semiconductor industry as memory stacks. All three have now passed the tests required for integration inside a standard commercial manufacturing process.
For investors,…
The NTA Story Is Becoming a Fee Growth Story
Since our last coverage, Powerhouse shares have risen 21% to 14 cents.
Our view was that the company was ripe for a re-rate. Net tangible assets (NTA) were sitting almost 1:1 with the market cap, while funds management and advisory were starting to add a more scalable…
Should I buy Tesla shares from Australia?
The world's largest and most famous electric vehicle maker may seem like a no-brainer for investors wanting a safe growth stock. After all, electric vehicle demand is only going to keep growing and there's a very long way to go. They are still a single digit percentage of used…
TechnologyOne Falls Despite Record Profit
TechnologyOne (ASX:TNE) slipped almost 4% today, even after handing in its 17th record first-half profit in a row. Annual recurring revenue, the lifeblood of any software business, grew 17%, and the UK business, TNE's biggest growth engine, jumped 23%. On paper, that sounds like a result worth celebrating. So why…
4DMedical (ASX:4DX) published peer-reviewed CT VQ data in AJRCCM showing lung surgery success rates lift from 46% to 76% via better patient selection.
Dotz Nano (ASX:DTZ) raises A$3.3 million at 4 cents per share with attaching options, as incoming CEO Nati Harpaz tops his personal stake above A$1m.
OFX Group (ASX:OFX) FY26 EBITDA fell 56% but a strategic review now in Phase 2 with multiple bidders reshapes the investment case.
